In addition to finding evidence of CCDC69 silencing led to cisplatin sensitivity in ovarian cancer cells, the bisulfite sequencing data showed that CCDC69 promotor region was heavily methylated in A2780 and A2780cis ovarian cancer cells. This evidence concerns the gene CCDC69 and ovarian carcinoma.